{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T23:18:29Z","timestamp":1786835909132,"version":"build-2736575974"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174373, 81603625"],"award-info":[{"award-number":["82174373, 81603625"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Study Design<\/jats:title><jats:p>Bibliometric and visualization analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To analyze the research landscapes and hotspots of Fournier's gangrene, and reveal the dynamic changes and development trend of research hotspots for the purpose of providing ideas and a basis for clinical and basic research in this field.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Research datasets were acquired from the Web of Science. The publication years were limited from January 1, 1900 to August 5, 2022. The bibliometric tools CiteSpace (v5.8) and VOSviewer (v1.6) were used to analyze the data and generate visualization knowledge maps. Trends in annual publications, distribution, H-index status, coauthorships status and research hotspots were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>According to the search strategy, we identified and enrolled 688 publications regarding to Fournier's gangrene. The number of published papers showed an overall upwards trend. The USA was the largest contributor, ranking first in total publications, citations and the H-index. The top 10 most productive institutions were all from the USA. De Simone B and Sartelli M were the most productive authors. There was close cooperation among countries, but the cooperation among institutions and authors had little contact and poor interactivity. The research hotspots included the pathogenesis factors and treatment. All the identified keywords were divided into 14 clusters, and the label of the latest cluster was \u201cempagliflozin\u201d. Prognosis and risk factors, emerging treatment methods, and pathogenesis were at the forefront of the Fournier's gangrene field and were predicted to be the next hot topics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The research of Fournier's gangrene has made some achievements, but the overall research level is still in the primary stage. The academic cooperation between different institutions and authors needs to be strengthened. At the early stage, the mainstream of research was the infected tissue and site, pathogenesis, and diagnosis of disease, while research on newly discovered sodium-glucose cotransporter 2 inhibitor, adjuvant therapy and prognostic factors may be the main directions in the future.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2023.1057486","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T06:41:40Z","timestamp":1676529700000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Bibliometric insights in fournier's gangrene: Research landscapes, turning points, and global trends"],"prefix":"10.3389","volume":"10","author":[{"given":"Jia-Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Fang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Bo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000445695","article-title":"Fournier's gangrene: epidemiology and outcomes in the general US population","volume":"97","author":"Sorensen","year":"2016","journal-title":"Urol Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1515\/med-2019-0114","article-title":"Fournier's gangrene and intravenous drug abuse: an unusual case report and review of the literature","volume":"14","author":"Zingaro","year":"2019","journal-title":"Open Med (Wars)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.12659\/MSM.905836","article-title":"Fournier's gangrene: clinical presentation of 13 cases","volume":"24","author":"Kuzaka","year":"2018","journal-title":"Med Sci Monit"},{"key":"B4","doi-asserted-by":"publisher","first-page":"942437","DOI":"10.5402\/2012\/942437","article-title":"Fournier's gangrene: current practices","volume":"2012","author":"Mallikarjuna","year":"2012","journal-title":"ISRN Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2147\/TCRM.S77326","article-title":"Pneumoscrotum: report of two different cases and review of the literature","volume":"11","author":"Cochetti","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"B6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrurol.2016.243","article-title":"A contemporary update on Fournier's Gangrene","volume":"14","author":"Hagedorn","year":"2016","journal-title":"Nat Rev Urol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1086\/511638","article-title":"Necrotizing soft-tissue infection: diagnosis and management","volume":"44","author":"Anaya","year":"2007","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijid.2019.12.030","article-title":"Fournier's gangrene mortality: a 17-year systematic review and meta-analysis","volume":"92","author":"El-Qushayri","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jemermed.2019.06.023","article-title":"Fournier gangrene: a review for emergency clinicians","volume":"57","author":"Montrief","year":"2019","journal-title":"J Emerg Med"},{"key":"B10","first-page":"481","article-title":"Fournier's gangrene secondary to locally advanced prostate cancer: case report and review of the literature","volume":"40","author":"Zingaro","year":"2019","journal-title":"Giornale di Chirurgia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e18948","DOI":"10.7759\/cureus.18948","article-title":"Fournier's gangrene diagnosis and treatment: a systematic review","volume":"13","author":"Lewis","year":"2021","journal-title":"Cureus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1756287215584740","article-title":"Contemporary diagnosis and management of Fournier's Gangrene","volume":"7","author":"Chennamsetty","year":"2015","journal-title":"Ther Adv Urol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.amsu.2017.02.043","article-title":"Case series of Fournier's Gangrene: affected body surface area\u2014the underestimated prognostic factor","volume":"16","author":"Morais","year":"2017","journal-title":"Ann Med Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.22037\/uj.v18i.6797","article-title":"Efficiency of hyperbaric oxygen therapy combined with negative-pressure wound therapy in the treatment strategy of Fournier's Gangrene -A retrospective study","volume":"19","author":"Michalczyk","year":"2021","journal-title":"Urol J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5173\/ceju.2020.0060","article-title":"Fournier's gangrene: a review of reconstructive options","volume":"73","author":"Insua-Pereira","year":"2020","journal-title":"Cent European J Urol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.14744\/tjtes.2020.68137","article-title":"Comparison of the newly developed Fournier's Gangrene mortality prediction model with existing models","volume":"28","author":"\u00c7om\u00e7al\u0131","year":"2022","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.14744\/tjtes.2020.66805","article-title":"Fournier's gangrene: five years\u2019 experience from a single center in Turkey","volume":"26","author":"Hatipoglu","year":"2020","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1177\/2192568220948832","article-title":"A bibliometric analysis and visualization of current research trends in the treatment of cervical spondylotic myelopathy","volume":"11","author":"Yin","year":"2021","journal-title":"Global Spine J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11655-020-3429-4","article-title":"A bibliometric analysis and visualization of current research trends in Chinese medicine for osteosarcoma","volume":"28","author":"Yin","year":"2022","journal-title":"Chin J Integr Med"},{"key":"B20","first-page":"724","article-title":"Citespace II: visualization and knowledge discovery in bibliographic databases","volume":"2005","author":"Synnestvedt","year":"2005","journal-title":"AMIA Annu Symp Proc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: vOSviewer, a computer program for bibliometric mapping","volume":"84","author":"Eck","year":"2010","journal-title":"Scientometrics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e3000384","DOI":"10.1371\/journal.pbio.3000384","article-title":"A standardized citation metrics author database annotated for scientific field","volume":"17","author":"Ioannidis","year":"2019","journal-title":"PLoS Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fphar.2020.00294","article-title":"Angelica sinensis (oliv.) DielsKnowledge mapping of (danggui) research: a scientometric study","volume":"11","author":"Lu","year":"2020","journal-title":"Front Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1445-2197.1996.tb01188.x","article-title":"Genitoperineal gangrene: experience in Singapore","volume":"66","author":"Ong","year":"1996","journal-title":"Aust N Z J Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.17159\/2078-5151\/2018\/v56n3a2409","article-title":"Fournier's gangrene: outcome analysis and prognostic factors","volume":"56","author":"Meki","year":"2018","journal-title":"South Afr J Surg"},{"key":"B26","first-page":"532","article-title":"Fournier's gangrene: our experience in 5 years, bibliographic review and assessment of the Fournier's Gangrene severity index","volume":"62","author":"Morua","year":"2009","journal-title":"Arch Esp Urol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.surge.2013.02.001","article-title":"Fournier's gangrene","volume":"11","author":"Shyam","year":"2013","journal-title":"Surgeon"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12610-022-00162-y","article-title":"Management of Fournier's Gangrene during the COVID-19 pandemic era: make a virtue out of necessity","volume":"32","author":"Paladini","year":"2022","journal-title":"Basic Clin Androl"},{"key":"B29","first-page":"38","author":"Ndubuisi","year":"2011","journal-title":"Fournier's Gangrene, Gangrene - Current Concepts and Management Options"},{"key":"B30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40064-014-0783-8","article-title":"The evaluation of microbiology and prognosis of fournier's Gangrene in past five years","volume":"4","author":"Tang","year":"2015","journal-title":"Springerplus"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e424","DOI":"10.1016\/j.ijid.2009.01.021","article-title":"The evaluation of microbiology and Fournier's Gangrene severity index in 27 patients","volume":"13","author":"Ulug","year":"2009","journal-title":"Int J Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.juro.2009.01.034","article-title":"Fournier's gangrene: population based epidemiology and outcomes","volume":"181","author":"Sorensen","year":"2009","journal-title":"J Urol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s15010-008-8169-x","article-title":"New insights into the epidemiology and etiology of Fournier's Gangrene: a review of 33 patients","volume":"37","author":"Czymek","year":"2009","journal-title":"Infection"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1111\/j.1445-2197.2005.03609.x","article-title":"Fournier's gangrene- a retrospective clinical study on forty-one patients","volume":"75","author":"Ayan","year":"2005","journal-title":"ANZ J Surg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4081\/aiua.2016.3.157","article-title":"Fournier's gangrene. A clinical review","volume":"88","author":"Singh","year":"2016","journal-title":"Arch Ital Urol Androl"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.4314\/ahs.v14i4.38","article-title":"Fournier's ganrene in the HIV era","volume":"14","author":"Ngugi","year":"2014","journal-title":"Afr Health Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF02307071","article-title":"Impact of immunodeficiency virus (HIV) on Fournier's gangrene: observations in Zambia","volume":"77","author":"Elem","year":"1995","journal-title":"Ann R Coll Surg Engl"},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1749-7922-8-13","article-title":"Fournier's gangrene our experience with 50 patients and analysis of factors affecting mortality","volume":"8","author":"Benjelloun","year":"2013","journal-title":"World J Emerg Surg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1001\/jamainternmed.2019.2813","article-title":"Association of sodium-glucose cotransporter 2 inhibitor treatment with risk of hospitalization for fournier gangrene among men","volume":"179","author":"Dave","year":"2019","journal-title":"JAMA Intern Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/dom.13531","article-title":"Comparative risk of genital infections associated with sodium-glucose co-transporter-2 inhibitors","volume":"21","author":"Dave","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"B41","doi-asserted-by":"publisher","first-page":"764","DOI":"10.7326\/M19-0085","article-title":"Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing cases","volume":"170","author":"Bersoff-Matcha","year":"2019","journal-title":"Ann Intern Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/1753-0407.12897","article-title":"Fournier's gangrene and sodium-glucose cotransporter 2 inhibitors: is there a causal association?","volume":"11","author":"Bloomgarden","year":"2019","journal-title":"J Diabetes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e000985","DOI":"10.1136\/bmjdrc-2019-000985","article-title":"Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier's Gangrene","volume":"8","author":"Yang","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B44","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ijscr.2020.11.100","article-title":"Fournier's gangrene under SGLT-2 inhibitor therapy: a literature review and case report","volume":"77","author":"Ellegard","year":"2020","journal-title":"Int J Surg Case Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.7860\/JCDR\/2013\/5535.3240","article-title":"Necrotising soft tissue infection-risk factors for mortality","volume":"7","author":"Kalaivani","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/01.ccm.0000129486.35458.7d","article-title":"The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections","volume":"32","author":"Wong","year":"2004","journal-title":"Crit Care Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00134-012-2558-4","article-title":"Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States nationwide inpatient sample","volume":"38","author":"Soh","year":"2012","journal-title":"Intensive Care Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13017-022-00448-6","article-title":"Outcome of necrotizing fasciitis and Fournier's Gangrene with and without hyperbaric oxygen therapy: a retrospective analysis over 10 years","volume":"17","author":"Mladenov","year":"2022","journal-title":"World J Emerg Surg"},{"key":"B49","first-page":"209","author":"Ruffo","year":"2013"},{"key":"B50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00345-020-03170-7","article-title":"The role of vacuum-assisted closure (VAC) therapy in the management of FOURNIER'S Gangrene: a retrospective multi-institutional cohort study","volume":"39","author":"Iacovelli","year":"2021","journal-title":"World J Urol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s11255-020-02705-6","article-title":"Vacuum-assisted closure device in the postoperative wound care for Fournier's Gangrene: a systematic review","volume":"53","author":"Franco-Buenaventura","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"994936","DOI":"10.3389\/fsurg.2022.994936","article-title":"Quality of life and sexual health after perineal reconstruction in fournier gangrene using pedicled anterolateral thigh flaps","volume":"9","author":"Rossi","year":"2022","journal-title":"Front Surg"},{"key":"B53","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/s0210-4806(09)72884-0","article-title":"Fournier's gangrene- from urological emergency to plastic surgery","volume":"33","author":"Horta","year":"2009","journal-title":"Actas Urol Esp"},{"key":"B54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/jso.27092","article-title":"Impact of etiology leading to abdominoperineal resection with anterolateral thigh flap reconstruction: a retrospective cohort study","volume":"127","author":"Meuli","year":"2022","journal-title":"J Surg Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bjps.2015.10.039","article-title":"Scrotal reconstruction with modified pudendal thigh flaps","volume":"69","author":"Mopuri","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.bjps.2010.07.018","article-title":"Reconstruction of scrotal and perineal defects in Fournier's Gangrene","volume":"64","author":"Chen","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"B57","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00006534-200202000-00030","article-title":"Anterolateral thigh fasciocutaneous island flaps in perineoscrotal reconstruction","volume":"109","author":"Yu","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"B58","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5505\/tjtes.2017.71509","article-title":"Usefulness of FGSI and UFGSI scoring systems for predicting mortality in patients with Fournier's Gangrene: a multicenter study","volume":"23","author":"Ureyen","year":"2017","journal-title":"Ulus Travma Acil Cerrahi Derg"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/j.1464-410X.2012.11082.x","article-title":"Is there a need for the Fournier's gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier's gangrene","volume":"110","author":"Roghmann","year":"2012","journal-title":"BJU Int"},{"key":"B60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11255-014-0897-5","article-title":"Evaluation of the utility of different scoring systems (FGSI, LRINEC and NLR) in the management of Fournier's gangrene","volume":"47","author":"Bozkurt","year":"2015","journal-title":"Int Urol Nephrol"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2023.1057486\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T06:41:46Z","timestamp":1676529706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2023.1057486\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":60,"alternative-id":["10.3389\/fsurg.2023.1057486"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2023.1057486","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"article-number":"1057486"}}